APCDs can Provide Important Insights for Surveilling the Opioid Epidemic, With Caveats

Agency for Healthcare Research and Quality . (2017). Data evaluation of All-Payer Claims Databases: Inventory and prioritization of measures to support the growing effort in transparency using All-Payer Claims Databases. https://www.ahrq.gov/data/apcd/backgroundrpt/data.html
Google Scholar Agency for Healthcare Research and Quality . (2018). All Payer’s Claim Databases. https://www.ahrq.gov/data/apcd/index.html#i
Google Scholar All-Payer Claims Database Council . (2020). Interactive State Report Map. https://www.apcdcouncil.org/state/map
Google Scholar All-Payer Claims Database Council . (2021). Common data layout. https://www.apcdcouncil.org/common-data-layout
Google Scholar Austin, A. M., Bynum, J. P. W., Maust, D. T., Gottlieb, D. J., Meara, E. (2018). Long-term implications of a short-term policy: Redacting substance abuse data. Health Affairs, 37(6), 975–979.
Google Scholar | Crossref Bachhuber, M. A., Saloner, B., Cunningham, C. O., Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673.
Google Scholar | Crossref | Medline | ISI Bartels, K., Fernandez-Bustamante, A., McWilliams, S. K., Hopfer, C. J., Mikulich-Gilbertson, S. K. (2018). Long-term opioid use after inpatient surgery—A retrospective cohort study. Drug and Alcohol Dependence, 187, 61–65.
Google Scholar | Crossref | Medline Bradford, A. C., Bradford, W. D. (2016). Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Affairs, 35(7), 1230–1236.
Google Scholar | Crossref | Medline Bradford, A. C., Bradford, W. D., Abraham, A., Bagwell Adams, G. (2018). Association between US state medical cannabis laws and opioid prescribing in the Medicare Part D population. JAMA Internal Medicine, 178(5), 667–672.
Google Scholar | Crossref | Medline Brummett, C. M., England, C., Evans-Shields, J., Kong, A. M., Lew, C. R., Henriques, C., Zimmerman, N. M., Pawasauskas, J., Oderda, G. (2019). Health care burden associated with outpatient opioid use following inpatient or outpatient surgery. Journal of Managed Care & Specialty Pharmacy, 25(9), 973–983.
Google Scholar | Crossref | Medline Burke, L. G., Zhou, X., Boyle, K. L., Orav, E. J., Bernson, D., Hood, M. E., Land, T., Bharel, M., Frakt, A. B. (2020). Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014. Addiction, 115(3), 493–504.
Google Scholar | Crossref | Medline Buttorff, C., Trujillo, A. J., Castillo, R., Vecino-Ortiz, A. I., Anderson, G. F. (2017). The impact of practice guidelines on opioid utilization for injured workers. American Journal of Industrial Medicine, 60(12), 1023–1030.
Google Scholar | Crossref | Medline Carman, K. G., Dworsky, M., Heins, S. E., Schwam, D., Shelton, S., Whaley, C. (2021). The history, promise and challenges of State All Payer Claims Databases: Background memo for the State All Payer Claims Database Advisory Committee to the Department of Labor. U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation.
Google Scholar Center for Improving Value in Health Care . (2020a). CO APCD overview. https://www.civhc.org/get-data/co-apcd-info/
Google Scholar Center for Improving Value in Health Care . (2020b). Plaintalk blog: Why the CO APCD does not have substance use disorder claims. https://www.civhc.org/2019/03/21/plaintalk-blog-why-the-co-apcd-does-not-have-substance-use-disorder-claims/
Google Scholar Center for Improving Value in Health Care . (2021). Colorado State Innovation Model. http://www.civhc.org/change-agent-gallery/colorado-state-innovation-model/
Google Scholar Centers for Disease Control and Prevention . (2014). Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. https://pubmed.ncbi.nlm.nih.gov/25228059/
Google Scholar Centers for Disease Control and Prevention . (2020). Data resources: Analyzing prescription data and morphine milligram equivalents (MME). https://www.cdc.gov/drugoverdose/resources/data.html
Google Scholar Centers for Medicare & Medicaid Services . (2021). Meaningful measures hub. https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityInitiativesGenInfo/MMF/General-info-Sub-Page#Measurement_Areas
Google Scholar Colorado Hospital Association . (2014). CHA Databank. http://www.cha.com/Member-Services/CHA-DATABANK.aspx
Google Scholar Colorado Revised Statutes Title 18—Criminal Code Article 18—Uniform Controlled Substances Act of 2013 . (2017).
Google Scholar Davis, J. M., Mendelson, B., Berkes, J. J., Suleta, K., Corsi, K. F., Booth, R. E. (2016). Public health effects of medical marijuana legalization in Colorado. American Journal of Preventive Medicine, 50(3), 373–379.
Google Scholar | Crossref | Medline Diaz-Perez, M. J., Hanover, R., Sites, E., Rupp, D., Courtemanche, J., Levi, E. (2019). Producing comparable cost and quality results from All-Payer Claims Databases. The American Journal of Managed Care, 25(5), e138–e144.
Google Scholar | Medline Dilonardo, J., Chalk, M., Mark, T. L., Coffey, R. M., & CSAT/CMHS Spending Estimates Team . (2000). Recent trends in the financing of substance abuse treatment: Implications for the future. Health Services Research, 35(5, Pt 3), 60–71.
Google Scholar | Medline Frakt, A. B., Bagley, N. (2015). Protection or harm? Suppressing substance-use data. The New England Journal of Medicine, 372(20), 1879–1881.
Google Scholar | Crossref | Medline Guy, G., Haegerich, T. M., Evans, M. E., Losby, J. L., Young, R., Jones, C. M. (2019). Vital signs: Pharmacy-based naloxone dispensing—United States, 2012-2018. Morbidity and Mortality Weekly Report, 68(31), 679–686.
Google Scholar | Crossref | Medline Heins, S. E., Feldman, D. R., Bodycombe, D., Wegener, S. T., Castillo, R. C. (2016). Early opioid prescription and risk of long-term opioid use among US workers with back and shoulder injuries: A retrospective cohort study. Injury Prevention, 22(3), 211–215.
Google Scholar | Crossref | Medline Heins, S. E., Sorbero, M. J., Jones, C. M., Dick, A. W., Stein, B. D. (2018). High-risk prescribing to Medicaid enrollees receiving opioid analgesics: Individual- and county-level factors. Substance Use & Misuse, 53(10), 1591–1601.
Google Scholar | Crossref | Medline IQVIA . (2018). Medicine use and spending in the U.S.: A review of 2017 and Outlook to 2022. IQVIA Institute for Human Data Science.
Google Scholar Kirson, N. Y., White, A. G., Birnbaum, H. G., Schiller, M., Waldman, T., Peterson, K., Ben-Joseph, R. H., Berner, T., Summers, K. H. (2012). Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl. Journal of Medical Economics, 15(1), 87–95.
Google Scholar | Crossref | Medline LeBaron, V. T., Camacho, F., Balkrishnan, R., Yao, N. A., Gilson, A. M. (2019). Opioid epidemic or pain crisis? Using the Virginia All Payer Claims Database to describe opioid medication prescribing patterns and potential harms for patients with cancer. Journal of Oncology Practice, 15(12), e997–e1009.
Google Scholar | Crossref Liu, S., Scholl, L., Hoots, B., Seth, P. (2020). Nonfatal drug and polydrug overdoses treated in emergency departments—29 states, 2018-2019. Morbidity and Mortality Weekly Report, 69(34), 1149–1155.
Google Scholar | Crossref | Medline Livingston, M. D., Barnett, T. E., Delcher, C., Wagenaar, A. C. (2017). Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. American Journal of Public Health, 107(11), 1827–1829.
Google Scholar | Crossref | Medline Malon, J., Shah, P., Koh, W. Y., Cattabriga, G., Li, E., Cao, L. (2018). Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database. BMC Public Health, 18(1), Article 810.
Google Scholar | Crossref | Medline Mattson, C. L., Tanz, L. J., Quinn, K., Kariisa, M., Patel, P., Davis, N. L. (2021). Trends and geographic patterns in drug and synthetic opioid overdose deaths — United States, 2013–2019. MMWR Morbidity and Mortality Weekly Report, 70(6), 202–207. http://dx.doi.org/10.15585/mmwr.mm7006a4
Google Scholar | Crossref McCarthy, D. (2020, December 10). State All-Payer Claims Databases: Tools for improving health care value, part 2 [Report]. The Commonwealth Fund.
Google Scholar National Institute on Drug Abuse . (2020). Colorado: Opioid-involved deaths and related harms. https://www.drugabuse.gov/drug-topics/opioids/opioid-summaries-by-state/colorado-opioid-involved-deaths-related-harms
Google Scholar Panhans, M. (2019). Adverse selection in ACA exchange markets: Evidence from Colorado. American Economic Journal: Applied Economics, 11(2), 1–36.
Google Scholar | Crossref Peters, A., Sachs, J., Porter, J., Love, D., Costello, A. (2014). The value of All-Payer Claims Databases to states. North Carolina Medical Journal, 75(3), 211–213.
Google Scholar | Crossref | Medline Rocco, P., Kelly, A. S., Beland, D., Kinane, M. (2017). The new politics of US health care prices: Institutional reconfiguration and the emergence of All-Payer Claims Databases. Journal of Health Politics, Policy and Law, 42(1), 5–52.
Google Scholar | Crossref | Medline Rudd, R. A., Seth, P., David, F., Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. Morbidity and Mortality Weekly Report, 65(50–51), 1445–1452.
Google Scholar | Crossref | Medline Saloner, B., Daubresse, M., Caleb Alexander, G. (2017). Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multistate population. Medical Care, 55(7), 669–676.
Google Scholar | Crossref | Medline Schieber, L. Z., Guy, G., Seth, P., Young, R., Mattson, C. L., Mikosz, C. A., Schieber, R. A. (2019). Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017. JAMA Network Open, 2(3), Article e190665.
Google Scholar | Crossref | Medline Scholl, L., Seth, P., Kariisa, M., Wilson, N., Baldwin, G. (2018). Drug and opioid-involved overdose deaths—United States, 2013-2017. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427.
Google Scholar | Crossref | Medline Shi, Y., Liang, D., Bao, Y., An, R., Wallace, M. S., Grant, I. (2019). Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug and Alcohol Dependence, 194, 13–19.
Google Scholar | Crossref | Medline Smart, R., Kase, C. A. M., Stein, B. (2018). Data sources and data-linking strategies to support research to address the opioid crisis. U.S. Department of Health and Human Services Assistant Secretary for Planning and Evaluation, Office of Health Policy.
Google Scholar Substance Abuse and Mental Health Services Administration . (2017). Federal Register: 42 CFR part 2: Confidentiality of substance use disorder patient records: Final rule—Rules and regulations (pp. 6052–6127). Department of Health and Human Services.
Google Scholar Tenney, L., McKenzie, L. M., Matus, B., Mueller, K., Newman, L. S. (2019). Effect of an opioid management program for Colorado workers’ compensation providers on adherence to treatment guidelines for chronic pain. American Journal of Industrial Medicine, 62(1), 21–29.
Google Scholar | Crossref | Medline Wen, H., Hockenberry, J. M. (2018). Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Internal Medicine, 178(5), 673–679.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif